Aqemia
Visit websiteApplied AI Research Scientist
Salary not disclosed3–5 yearsHybrid
- Platform
- Paris
- Full time
- Yesterday
About the role
The Applied AI Research Scientist will work at the intersection of machine learning and molecular science to advance drug discovery. This role involves a balance of developing cutting-edge ML models for molecular property prediction and applying these models to drive decision-making in internal and partnered drug discovery programs. The successful candidate will collaborate closely with multidisciplinary teams of chemists, biologists, and engineers to translate research into actionable therapeutic insights.
Responsibilities
- Design and implement novel Deep Learning algorithms including GNNs, generative, and physics-based models.
- Take part in cutting-edge research and bibliographic exploration.
- Collaborate with research and drug discovery teams to translate models into actionable insights.
- Develop robust ML models from molecular and biological data.
- Collaborate with chemists and biologists to deliver results that drive compound prioritization.
- Own ML workstreams from start to finish including goals, timelines, and stakeholder communication.
- Deliver models and predictions that scientists can use in their everyday workflows.
Required skills
- Deep Learning
- GNNs
- PyTorch
- TensorFlow
- Scikit-learn
- Python
- Scientific computing
- Machine Learning
Nice to have
- Drug discovery
- Computational chemistry
- Physics
- Generative models
- Diffusion models
- VAEs
- Autoregressive models
- Structure-based drug design
- Protein-ligand interactions
- HPC
Qualifications
- MSc or PhD in Computer Science, Machine Learning, Computational Chemistry, or related field
- 3-5 years of experience applying ML in scientific or industrial settings
About the Company
AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. The company uses its proprietary QEMI platform, which combines physics-based modeling, statistical mechanics, and generative AI to design novel drug candidates from first principles.